The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial (LEADER) led to a paradigm shift in the wider use of GLP-1RA from promising antihyperglycemic agents to cornerstone cardiometabolic therapies, demonstrating the significant reduction of major adverse cardiovascular events (MACE) with the use of liraglutide in the population with type 2 diabetes mellitus (T2DM) [12, 13]
10.1038/s41467-020-16525-w [DOI] [PMC free article] [PubMed] [Google Scholar] 137.Kaneko, C
GSH is abundant in most cells, so we adopted a physical organic chemistry approach to precisely tune the reactivity to distinguish between normal and pathological states
Kokic, G
If you are deemed suitable for treatment and wish to go ahead then treatment can be performed on the same day as the consultation or you can book a future appointment
AMA Longevity optimization through strength benchmarks, VO max targets, nutrition principles, brain health, supplements, GLP-1 RAs, wearables, and more #382 AMA #80: Longevity optimization through strength benchmarks, VO max targets, nutrition principles, brain health, supplements, GLP-1 RAs, wearables, and more In this special Ask Me Anything (AMA) episode, Peter answers a wide range of questions spanning the topics that come up most often in conversations about longevity and health optimization
